Skip to main content

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Cipla Medpro collaborate with Serum Institute to provide vaccines in South Africa

    Cipla Medpro (Pty) Ltd., South African subsidiary of Cipla Ltd. has recently entered into an exclusive agreement with the world’s largest vaccine manufacturer, Serum Institute of India (SII) in South Africa. The partnership will not only enable affordable and accessible vaccines for South Africans, but will also facilitate a reliable supply stream to the South African Government.

  • Alcoholism may be Manage by Decoding Brain Cells' Moods

    A new discovery by Indian researchers suggest that brain cells also have different moods, a finding that could impact artificial intelligence and management of healthcare issues like autism and alcoholism. These brain cells called Purkinje cells, located in the cerebellum at the base of the brain, are essential for our body's balance, co-ordination and the capacity to learn new skills such as riding a bicycle or playing a piano.

  • Gout drug can help treat Heart Attack Patients

    A cheap, widely available drug used to treat gout could help heart attack survivors live longer and healthier lives, a new study led by an Indian-origin scientist in Australia has found. The study led by Dr Sanjay Patel from the Heart Research Institute (HRI) shows that an anti-inflammatory medication used to treat gout and combat arthritis also improves the heart health of people who have suffered a heart attack or other major heart event. The researchers said they have proved that the widely available drug is both safe and profoundly effective in reducing local cardiac inflammation.

  • Scientists sequence Tulsi Genome for Medicinal Properties

    A team of researchers from the National Centre for Biological Sciences (NCBS), Bangalore, has succeeded in sequencing the genome of Tulsi, a step which will help identify the genes responsible for production of compounds with potential medicinal benefits. The team which included researchers from NCBS, inStem and CCAMP (Centre for Cellular and Molecular Platforms), all members of the Bangalore Life Sciences Cluster, used five different types of Tulsi, (Ocimum tenuflorium subtype Rama, O. tenuflorium subtype Krishna, O. gratissimum, O. saccharicum and O. kilmund) to collect the genomic data.

Subscribe to Pharma News

Search this website